Patient with Down syndrome and relapsed acute lymphoblastic leukemia with sustained remission despite only partial R3 chemotherapy.
Zhongbo HuKristen A VanHeystJignesh DalalLisa HackneyPublished in: Clinical case reports (2021)
DS-ALL has a higher rate of relapse and treatment-related mortality. The newer immunotherapies are potentially better options. Relapsed ALL with positive MRD has a poor prognosis. Transient long-term remission after ALL relapse due to partial chemotherapy combined severe infection is rare.
Keyphrases
- acute lymphoblastic leukemia
- poor prognosis
- long non coding rna
- allogeneic hematopoietic stem cell transplantation
- locally advanced
- disease activity
- acute myeloid leukemia
- multiple myeloma
- free survival
- hodgkin lymphoma
- diffuse large b cell lymphoma
- case report
- ulcerative colitis
- cardiovascular events
- early onset
- squamous cell carcinoma
- type diabetes
- rectal cancer
- radiation therapy
- cerebral ischemia
- smoking cessation